Sertraline and Alprazolam in the Treatment of Panic Disorder

Alprazolam Sertraline Agoraphobia
DOI: 10.17305/bjbms.2005.3292 Publication Date: 2018-05-30T23:14:23Z
ABSTRACT
A compared, 12 week, placebo controlled study, with fixed dose, outpatient study of patients diagnosed panic disorder and without agoraphobia according to ICD-10, was conducted evaluate the efficacy safety sertraline alprazolam. The included 40 patients, divided in two groups. We evaluated number ICD-10-defined attacks, anticipatory anxiety. All were aged 18 year older randomized either or Sertraline applied doses 20 mg/day alprazolam 1-1,5 significantly reduced frequency attacks symptoms anxiety
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....